ERNEXA THERAPEUTICS INC (ERNA:NASDAQ)

$6.16 -0.395 (-6.0259%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 75

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) News Sources

Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026

31-03-2026

yahoo.com

Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split

30-04-2026

yahoo.com

Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models

06-05-2026

yahoo.com

Ernexa Therapeutics (ERNA) Preclinical Data Shows 100% Survival and Complete Tumor Clearance in Ovarian Cancer Models

06-05-2026

advfn.com

Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101

11-05-2026

yahoo.com

Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners

18-05-2026

247wallst.com

Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity

20-05-2026

yahoo.com

ERNA Stock Shoots Up 140% in a Month: Here's What You Should Know

20-05-2026

yahoo.com

Ernexa Therapeutics Successfully Completes Key Manufacturing and IND Preparation Milestones for ERNA-101 Toward First-in-Human Clinical Development

27-05-2026

yahoo.com

Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer

09-06-2026

yahoo.com

ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) Sentiment Trend

0 25 50 75 100 90 84 90 81 66 5 76 82 90 81 31-03-2026 30-04-2026 06-05-2026 11-05-2026 18-05-2026 20-05-2026 27-05-2026 09-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) FAQs

toggle

What is the current price of ERNEXA THERAPEUTICS INC (ERNA:NASDAQ)?

The current price of ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) is $6.16.


toggle

ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) absolute price change since previous trading day?

The absolute price change of ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) since the previous trading day is $-0.395.


toggle

ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) percentage price change since previous trading day?

The percentage price change of ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) since the previous trading day is -6.0259%.


toggle

What is the most recent average sentiment score for ERNEXA THERAPEUTICS INC (ERNA:NASDAQ)?

The most recent average sentiment score for ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) is 75 out of 100.


toggle

What is the most recent average sentiment for ERNEXA THERAPEUTICS INC (ERNA:NASDAQ)?

The most recent sentiment for ERNEXA THERAPEUTICS INC (ERNA:NASDAQ) is .


SEC-8K** Filing Available For ERNEXA THERAPEUTICS INC (ERNA:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.